- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03320967
Copeptin and Arterial Hypotension in Critically Ill Paediatric and Neonatal Intensive Care Patients (COPNIC)
July 3, 2019 updated by: Vincenzo Cannizzaro
COpeptin in Critically Ill Paediatric and Neonatal Intensive Care Patients and Its Association With Arterial Hypotension. A Single-centre Prospective Observational Study.
Blood copeptin will be measured during the routine treatment of neonates, children and adolescents on the Intensive Care Unit of the University Children's Hospital Zurich at different time points (admission, 12, 24, 48, 96, 168 hours after admission).
These values will be primarily analysed for their variability and their association with arterial hypotension.
Blood samples will be drawn together with otherwise medically indicated blood withdrawals to avoid extra harm.
Further, copeptin values will be compared to clinical and vital parameters, all of them open-label available during clinical routine.
Copeptin's predictive value for patients' outcome will be analysed as secondary outcome.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
170
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Zürich, Switzerland, 8032
- University Children's Hospital Zurich
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 17 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
This is a study designed to explore Copeptin values in all kinds of critically ill paediatric patients.
Patients with normal blood pressures will allow calculating Copeptin reference values for the ones requiring cardiovascular support.
Therefore, all patients, irrespective of their medical condition (e.g.
medical or surgical, mildly or severely affected) and their age (neonates to adolescents) admitted to the Intensive Care Unit of the University's Children Hospital Zurich will be eligible, as long as they fulfil the mentioned inclusion criteria.
Description
Inclusion Criteria:
- Age: first day of life until 18th birthday.
- Ability of the care taker or the adolescent (if≥14 years of age) to understand verbal and written instructions and informed consent in German.
Exclusion Criteria:
- Care taker or adolescent (if ≥14 years of age) unwilling to give written informed consent.
- Care taker or adolescent (if ≥14 years of age) not understanding German and without a family member able to translate.
- Adolescent (if ≥14 years of age) unwilling to give written informed consent following sedation < 24 hours.
- Care takers of long-term sedated (>24 hours) adolescents (if ≥14 years of age) unwilling to give written informed consent or not present within 24 hours.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood copeptin in arterial normo- and hypotension
Time Frame: Up to 168 hours.
|
Average change of blood copeptin in patients with both arterial normo- and hypotension and different pathologies.
|
Up to 168 hours.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Length of stay on the intensive care unit
Time Frame: Up to 168 hours.
|
Association of copeptin values with length of stay on the intensive care unit.
|
Up to 168 hours.
|
Length of respiratory support
Time Frame: Up to 168 hours.
|
Association of copeptin values with length of respiratory Support.
|
Up to 168 hours.
|
Length and dose of catecholamine therapy
Time Frame: Up to 168 hours.
|
Association of copeptin values with length and dose of catecholamine therapy.
|
Up to 168 hours.
|
Rate of death
Time Frame: Up to 168 hours.
|
Rate of death at 28 days.
|
Up to 168 hours.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Vinzenco Cannizzaro, MD, PhD, University Children's Hospital, Zurich
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
December 4, 2017
Primary Completion (ACTUAL)
June 30, 2019
Study Completion (ACTUAL)
June 30, 2019
Study Registration Dates
First Submitted
October 4, 2017
First Submitted That Met QC Criteria
October 20, 2017
First Posted (ACTUAL)
October 25, 2017
Study Record Updates
Last Update Posted (ACTUAL)
July 5, 2019
Last Update Submitted That Met QC Criteria
July 3, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KISPI-COPNIC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arterial Hypotension in Critically Ill Neonatal and Pediatric Patients
-
French Society for Intensive CareCompleted
-
University of PittsburghNational Institute on Aging (NIA)CompletedPhysician-Family Communication in Intensive Care Units | Surrogate Decision-making for Critically Ill Patients | Critically Ill Intensive Care Unit PatientsUnited States
-
Assiut UniversityUnknownDiaphragmatic Dysfunction in Critically Ill Patients
-
Assiut UniversityCompletedSedation in Critically Ill COPD Patients
-
University of ChicagoTerminatedJugular Venous Pulse Measurement in Critically Ill PatientsUnited States
-
Shanghai Zhongshan HospitalNot yet recruitingEmergency Tracheal Intubation in Critically Ill Patients
-
Goethe UniversityUnknownDrug Monitoring of Antiinfectives in Critically Ill Patients Receiving Extracorporeal Life SupportGermany
-
Unity Health TorontoCompletedHyperglycemia in Critically Ill PatientsCanada
-
National Taiwan University HospitalActive, not recruitingUltrasound for Confirmation of Gastric Tube Placement in Critically Ill Patients Under Invasive Mechanical VentilationTaiwan
-
University Hospital, RouenCompletedSedated Patients | Critically Ill Patients Under Mechanical VentilationFrance
Clinical Trials on Copeptin in plasma
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
The University of Hong KongFeinstein Institute for Medical ResearchUnknownAdenocarcinoma of Lung (Disorder)Hong Kong
-
I.M. Sechenov First Moscow State Medical UniversityUniversity of Basel; Universiteit AntwerpenCompletedPulmonary Hypertension | Microvascular Angina | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection FractionRussian Federation
-
University Hospital, Strasbourg, FranceRecruiting
-
Jan Biziel University Hospital No 2 in BydgoszczUnknown
-
University of AarhusOdense University Hospital; Aarhus University Hospital; Rikshospitalet University...RecruitingPost-transplant Lymphoproliferative Disorder | EBV Infection | EBV Viremia | Epstein-Barr Virus Associated Lymphoproliferative DisorderDenmark, Norway
-
Sanford HealthUniversity of North DakotaCompletedStroke, AcuteUnited States
-
First Affiliated Hospital, Sun Yat-Sen UniversityCompleted
-
Nova Scotia Health AuthorityNot yet recruiting
-
Tanta UniversityCompletedRole of Platelet Rich Plasma in Wound HealingEgypt